Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
3.420
-0.090 (-2.56%)
At close: Jan 16, 2026, 4:00 PM EST
3.470
+0.050 (1.46%)
After-hours: Jan 16, 2026, 7:15 PM EST
Lantern Pharma Market Cap
Lantern Pharma has a market cap or net worth of $38.25 million as of January 16, 2026. Its market cap has increased by 11.18% in one year.
Market Cap
38.25M
Enterprise Value
25.98M
1-Year Change
11.18%
Ranking
Category
Stock Price
$3.42
Market Cap Chart
Since June 11, 2020, Lantern Pharma's market cap has increased from $30.33M to $38.25M, an increase of 26.12%. That is a compound annual growth rate of 4.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 38.25M | 12.87% |
| Dec 31, 2025 | 33.89M | -1.50% |
| Dec 31, 2024 | 34.40M | -26.05% |
| Dec 29, 2023 | 46.52M | -29.06% |
| Dec 30, 2022 | 65.58M | -26.55% |
| Dec 31, 2021 | 89.28M | -25.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |